Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
04/06 04:04
Sangamo Therapeutics | 4:持股变动声明-高管 Duraibabu Prathyusha
02/28 06:18
Sangamo Therapeutics | 4:持股变动声明-高管 Dubois-Stringfellow Nathalie
02/28 06:18
Sangamo Therapeutics | 4:持股变动声明-高管 Willoughby Scott B.
02/28 06:17
Sangamo Therapeutics | 4:持股变动声明-高管 Pooler Amy
02/28 06:17
Sangamo Therapeutics | 4:持股变动声明-高管 Macrae Sandy
02/28 06:17
Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.10%)
02/14 11:36
Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)
02/13 08:15
Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
02/10 01:20
Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.9%)
01/27 00:54
Sangamo Therapeutics | 4:持股变动声明-高管 Pooler Amy
01/25 05:46
Sangamo Therapeutics | 4:持股变动声明-高管 Willoughby Scott B.
01/25 05:45
Sangamo Therapeutics | 4:持股变动声明-高管 Duraibabu Prathyusha
01/25 05:45
Sangamo Therapeutics | 4:持股变动声明-高管 Dubois-Stringfellow Nathalie
01/25 05:45
Sangamo Therapeutics | 4:持股变动声明-高管 Macrae Sandy
01/25 05:41
Sangamo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.53%)
01/22 13:00
Sangamo Therapeutics | 4:持股变动声明-高管 Willoughby Scott B.
2023/11/29 05:20
Sangamo Therapeutics | 4:持股变动声明-高管 McClung David Mark
2023/11/29 05:19
Sangamo Therapeutics | 4:持股变动声明-高管 Macrae Sandy
2023/11/29 05:19
Sangamo Therapeutics | 4:持股变动声明-高管 Fontenot Jason D.
2023/11/29 05:18
暂无数据
暂无数据